Insider Transactions in Q4 2025 at 180 Life Sciences Corp. (ATNF)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2025
|
Ryan Lewis Smith Director |
BUY
Bona fide gift
|
Indirect |
16,718
+50.0%
|
-
|
|
Dec 01
2025
|
Ryan Lewis Smith Director |
SELL
Bona fide gift
|
Direct |
16,718
-100.0%
|
-
|
|
Nov 14
2025
|
Mc Andrew Rudisill Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
370,000
+47.12%
|
-
|
|
Nov 14
2025
|
Mc Andrew Rudisill Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
410,865
-37.58%
|
-
|
|
Nov 14
2025
|
Ryan Lewis Smith Director |
BUY
Bona fide gift
|
Indirect |
267,137
+50.0%
|
-
|
|
Nov 14
2025
|
Ryan Lewis Smith Director |
SELL
Bona fide gift
|
Direct |
267,137
-36.71%
|
-
|
|
Nov 14
2025
|
Andrew P Suckling Director |
BUY
Bona fide gift
|
Indirect |
149,020
+50.0%
|
-
|
|
Nov 14
2025
|
Andrew P Suckling Director |
SELL
Bona fide gift
|
Direct |
149,020
-50.0%
|
-
|
|
Nov 14
2025
|
Crystal Jane Heter Director |
BUY
Bona fide gift
|
Indirect |
182,742
+50.0%
|
-
|
|
Nov 14
2025
|
Crystal Jane Heter Director |
SELL
Bona fide gift
|
Direct |
182,742
-50.0%
|
-
|
|
Nov 14
2025
|
Jason Griffin New Director |
BUY
Bona fide gift
|
Indirect |
218,456
+50.0%
|
-
|
|
Nov 14
2025
|
Jason Griffin New Director |
SELL
Bona fide gift
|
Direct |
218,456
-30.74%
|
-
|
|
Nov 12
2025
|
John Tazewell Saunders Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,447
-21.45%
|
-
|
|
Nov 12
2025
|
John Tazewell Saunders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109,312
+50.0%
|
-
|
|
Nov 12
2025
|
Mc Andrew Rudisill Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
271,635
-19.9%
|
-
|
|
Nov 12
2025
|
Mc Andrew Rudisill Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,365,000
+50.0%
|
-
|
|
Nov 12
2025
|
Ryan Lewis Smith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
176,613
-19.53%
|
-
|
|
Nov 12
2025
|
Ryan Lewis Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
887,500
+49.53%
|
-
|
|
Nov 12
2025
|
Andrew P Suckling Director |
SELL
Payment of exercise price or tax liability
|
Direct |
175,854
-27.07%
|
-
|
|
Nov 12
2025
|
Andrew P Suckling Director |
BUY
Grant, award, or other acquisition
|
Direct |
649,748
+50.0%
|
-
|
|
Nov 12
2025
|
Crystal Jane Heter Director |
SELL
Payment of exercise price or tax liability
|
Direct |
142,132
-21.87%
|
-
|
|
Nov 12
2025
|
Crystal Jane Heter Director |
BUY
Grant, award, or other acquisition
|
Direct |
649,748
+50.0%
|
-
|
|
Nov 12
2025
|
Jason Griffin New Director |
SELL
Payment of exercise price or tax liability
|
Direct |
257,794
-26.6%
|
-
|
|
Nov 12
2025
|
Jason Griffin New Director |
BUY
Grant, award, or other acquisition
|
Direct |
952,500
+50.0%
|
-
|